Application 216608
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 300MG/VIAL | No | No |
| 002 | ARIPIPRAZOLE | ARIPIPRAZOLE | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 400MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216608-001 | ARIPIPRAZOLE | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | ||
| A216608-002 | ARIPIPRAZOLE | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | AP | 2024-12-03 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-001 | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216608-002 | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 2024-12-03 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216608-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216608-002 | AP | 1 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aripiprazole | ARIPIPRAZOLE | Coupler LLC | 52bbfc8f-fa17-839e-e063-6394a90a6316 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Major Pharmaceuticals | 573c6bb6-941f-4413-8c23-826025385864 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| aripiprazole | ARIPIPRAZOLE | REMEDYREPACK INC. | 9b695d4b-3794-4b89-8575-6feb83697ccc | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | c092a736-16e2-4dd0-8769-cb766a62f4d9 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Coupler LLC | 512874e6-6d00-2623-e063-6394a90aa4bc | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Coupler LLC | 50214c47-2ea3-b373-e063-6394a90aad23 | 2026-04-23 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | REMEDYREPACK INC. | 6f580e75-61ab-4c7b-bb3f-f027a9603f84 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| ABILIFY MAINTENA | ARIPIPRAZOLE | Otsuka America Pharmaceutical, Inc. | ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | REMEDYREPACK INC. | 433cdc7d-465a-4ad4-bd84-cabd37e15f51 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| aripiprazole | ARIPIPRAZOLE | Major Pharmaceuticals | 969c17aa-6abc-413c-8561-f1ad8fdde3e5 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Preferred Pharmaceuticals, Inc. | 36fb0c13-dfae-46ac-bb71-0b53fe5649f4 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Preferred Pharmaceuticals Inc. | 02a4af27-c83c-4166-950c-7a1cb12d198d | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | ff8dc838-ca1a-49d3-8938-5ae645574a75 | 2026-03-05 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | REMEDYREPACK INC. | 2bc00231-c2e7-4b9d-93a1-fb796fd8d591 | 2026-02-11 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 1e8d889e-126b-4627-a2cc-34f2d35a5d67 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 1ef9e44f-5672-47c2-97e9-286e1b84417d | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | 4bda6f17-d87c-4009-b329-99275c56106f | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Bryant Ranch Prepack | fb40b669-4e37-4087-8fb1-3ac140543602 | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | A-S Medication Solutions | 554db933-aa80-4685-bcd5-58c84571c19c | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
| Aripiprazole | ARIPIPRAZOLE | Coupler LLC | 47430dfa-9377-6c31-e063-6394a90a86a9 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Aripiprazole ARIPIPRAZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81193 | ORIG | 2025-02-10 |